메뉴 건너뛰기




Volumn 65, Issue 19, 2005, Pages 8951-8960

Effect of p53 status and STAT1 on chemotherapy-induced, fas-mediated apoptosis in colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FAS ANTIGEN; FLUOROURACIL; IRINOTECAN; MESSENGER RNA; MUTANT PROTEIN; OXALIPLATIN; PROTEIN P53; RALTITREXED; SERINE; SMALL INTERFERING RNA; STAT1 PROTEIN;

EID: 25444481030     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0961     Document Type: Article
Times cited : (61)

References (41)
  • 1
    • 0026706261 scopus 로고
    • Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
    • Oehm A, Behrmann I, Falk W, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-15.
    • (1992) J Biol Chem , vol.267 , pp. 10709-10715
    • Oehm, A.1    Behrmann, I.2    Falk, W.3
  • 2
    • 0033613143 scopus 로고    scopus 로고
    • Caspase activation: The induced-proximity model
    • Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 1999;96:10964-7.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 10964-10967
    • Salvesen, G.S.1    Dixit, V.M.2
  • 3
    • 0242432345 scopus 로고    scopus 로고
    • Many cuts to ruin: A comprehensive update of caspase substrates
    • Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100.
    • (2003) Cell Death Differ , vol.10 , pp. 76-100
    • Fischer, U.1    Janicke, R.U.2    Schulze-Osthoff, K.3
  • 4
    • 0031743648 scopus 로고    scopus 로고
    • p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
    • Muller M, Wilder S, Bannasch D, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188:2033-45.
    • (1998) J Exp Med , vol.188 , pp. 2033-2045
    • Muller, M.1    Wilder, S.2    Bannasch, D.3
  • 5
    • 0034955033 scopus 로고    scopus 로고
    • New chemotherapy approaches in colorectal cancer
    • Grothey A, Schmoll HJ. New chemotherapy approaches in colorectal cancer. Curr Opin Oncol 2001;13:275-86.
    • (2001) Curr Opin Oncol , vol.13 , pp. 275-286
    • Grothey, A.1    Schmoll, H.J.2
  • 6
    • 0027509209 scopus 로고
    • Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
    • Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64.
    • (1993) Gastroenterology , vol.104 , pp. 57-64
    • Bell, S.M.1    Scott, N.2    Cross, D.3
  • 7
    • 0026496488 scopus 로고
    • Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis
    • Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992;70:2778-84.
    • (1992) Cancer , vol.70 , pp. 2778-2784
    • Yamaguchi, A.1    Kurosaka, Y.2    Fushida, S.3
  • 8
    • 2542496862 scopus 로고    scopus 로고
    • The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
    • Longley DB, Allen WL, McDermott U, et al. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Clin Cancer Res 2004;10:3562-71.
    • (2004) Clin Cancer Res , vol.10 , pp. 3562-3571
    • Longley, D.B.1    Allen, W.L.2    McDermott, U.3
  • 9
    • 20244383713 scopus 로고    scopus 로고
    • Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma
    • Diez M, Pollan M, Muguerza JM, et al. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer 2000;88:35-41.
    • (2000) Cancer , vol.88 , pp. 35-41
    • Diez, M.1    Pollan, M.2    Muguerza, J.M.3
  • 10
    • 2442659386 scopus 로고    scopus 로고
    • Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: A North Central Cancer Treatment Group Study
    • Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004;22:1572-82.
    • (2004) J Clin Oncol , vol.22 , pp. 1572-1582
    • Garrity, M.M.1    Burgart, L.J.2    Mahoney, M.R.3
  • 11
    • 0035980014 scopus 로고    scopus 로고
    • Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function
    • Kong XT, Gao H, Stanbridge EJ. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function. J Biol Chem 2001;276:32990-3000.
    • (2001) J Biol Chem , vol.276 , pp. 32990-33000
    • Kong, X.T.1    Gao, H.2    Stanbridge, E.J.3
  • 12
    • 0037567586 scopus 로고    scopus 로고
    • Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells
    • Gurova KV, Rokhlin OW, Budanov AV, et al. Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Res 2003;63:2905-12.
    • (2003) Cancer Res , vol.63 , pp. 2905-2912
    • Gurova, K.V.1    Rokhlin, O.W.2    Budanov, A.V.3
  • 13
    • 0037165631 scopus 로고    scopus 로고
    • A mutant p53 can activate apoptosis through a mechanism distinct from those induced by wild type P53
    • He M, Rennie PS, Dragowska V, Nelson CC, Jia W. A mutant p53 can activate apoptosis through a mechanism distinct from those induced by wild type P53. FEBS Lett 2002;517:151-4.
    • (2002) FEBS Lett , vol.517 , pp. 151-154
    • He, M.1    Rennie, P.S.2    Dragowska, V.3    Nelson, C.C.4    Jia, W.5
  • 14
    • 0037063173 scopus 로고    scopus 로고
    • Novel gain of function activity of p53 mutants: Activation of the dUTPase gene expression leading to resistance to 5-fluorouracil
    • Pugacheva EN, Ivanov AV, Kravchenko JE, Kopnin BP, Levine AJ, Chumakov PM. Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene 2002;21:4595-600.
    • (2002) Oncogene , vol.21 , pp. 4595-4600
    • Pugacheva, E.N.1    Ivanov, A.V.2    Kravchenko, J.E.3    Kopnin, B.P.4    Levine, A.J.5    Chumakov, P.M.6
  • 15
    • 0029027667 scopus 로고
    • Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent
    • Forrester K, Lupold SE, Ott VL, et al. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 1995;10:2103-11.
    • (1995) Oncogene , vol.10 , pp. 2103-2111
    • Forrester, K.1    Lupold, S.E.2    Ott, V.L.3
  • 16
    • 0032125574 scopus 로고    scopus 로고
    • IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
    • Xu X, Fu XY, Plate J, Chong AS. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 1998;58:2832-7.
    • (1998) Cancer Res , vol.58 , pp. 2832-2837
    • Xu, X.1    Fu, X.Y.2    Plate, J.3    Chong, A.S.4
  • 17
    • 0035958846 scopus 로고    scopus 로고
    • Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701
    • Stephanou A, Scarabelli TM, Brar BK, et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001;276:28340-7.
    • (2001) J Biol Chem , vol.276 , pp. 28340-28347
    • Stephanou, A.1    Scarabelli, T.M.2    Brar, B.K.3
  • 18
    • 0034254726 scopus 로고    scopus 로고
    • How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
    • Chatterjee-Kishore M, Wright KL, Ting JP, Stark GR. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 2000;19:4111-22.
    • (2000) EMBO J , vol.19 , pp. 4111-4122
    • Chatterjee-Kishore, M.1    Wright, K.L.2    Ting, J.P.3    Stark, G.R.4
  • 20
    • 0023945379 scopus 로고
    • In vitro pharmacodynamics of 1-β-D-arabinofuranosylcytosine: Synergy of antitumor activity with cis-diamminedichloroplatinum(II)
    • Kern DH, Morgan CR, Hildebrand-Zanki SU. In vitro pharmacodynamics of 1-β-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II). Cancer Res 1988;48:117-21.
    • (1988) Cancer Res , vol.48 , pp. 117-121
    • Kern, D.H.1    Morgan, C.R.2    Hildebrand-Zanki, S.U.3
  • 22
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 23
    • 0023873482 scopus 로고
    • Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture
    • Kano Y, Ohnuma T, Okano T, Holland JF. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 1988;48:351-6.
    • (1988) Cancer Res , vol.48 , pp. 351-356
    • Kano, Y.1    Ohnuma, T.2    Okano, T.3    Holland, J.F.4
  • 24
    • 0034635373 scopus 로고    scopus 로고
    • Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
    • Munsch D, Watanabe-Fukunaga R, Bourdon JC, et al. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J Biol Chem 2000;275:3867-72.
    • (2000) J Biol Chem , vol.275 , pp. 3867-3872
    • Munsch, D.1    Watanabe-Fukunaga, R.2    Bourdon, J.C.3
  • 25
    • 0025916387 scopus 로고
    • The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
    • Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
    • (1991) Cell , vol.66 , pp. 233-243
    • Itoh, N.1    Yonehara, S.2    Ishii, A.3
  • 26
    • 0028888832 scopus 로고
    • Characterization of human Fas gene. Exon/intron organization and promoter region
    • Cheng J, Liu C, Koopman WJ, Mountz JD. Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol 1995;154:1239-45.
    • (1995) J Immunol , vol.154 , pp. 1239-1245
    • Cheng, J.1    Liu, C.2    Koopman, W.J.3    Mountz, J.D.4
  • 27
    • 0027434082 scopus 로고
    • Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways
    • Muller M, Laxton C, Briscoe J, et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J 1993;12:4221-8.
    • (1993) EMBO J , vol.12 , pp. 4221-4228
    • Muller, M.1    Laxton, C.2    Briscoe, J.3
  • 28
    • 5544237608 scopus 로고    scopus 로고
    • Final results of a randomised trial comparing "Tomudex" (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
    • "Tomudex" Colorectal Cancer Study Group
    • Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing "Tomudex" (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. Ann Oncol 1996;7:961-5.
    • (1996) Ann Oncol , vol.7 , pp. 961-965
    • Cunningham, D.1    Zalcberg, J.R.2    Rath, U.3
  • 29
    • 0344783805 scopus 로고    scopus 로고
    • Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
    • Digestive Group of French Federation of Cancer Centers
    • Becouarn Y, Ychou M, Ducreux M, et al. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol 1998;16:2739-44.
    • (1998) J Clin Oncol , vol.16 , pp. 2739-2744
    • Becouarn, Y.1    Ychou, M.2    Ducreux, M.3
  • 30
    • 0030818926 scopus 로고    scopus 로고
    • Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
    • Pilot HC, Wender DB, O'Connell MJ, et al. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 1997;15:2910-9.
    • (1997) J Clin Oncol , vol.15 , pp. 2910-2919
    • Pilot, H.C.1    Wender, D.B.2    O'Connell, M.J.3
  • 31
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
    • Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229-37.
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    Andre, T.2    Achille, E.3
  • 32
    • 0032802737 scopus 로고    scopus 로고
    • Acute toxicity of an anti-Fas antibody in mice
    • Kakinuma C, Takagaki K, Yatomi T, et al. Acute toxicity of an anti-Fas antibody in mice. Toxicol Pathol 1999;27:412-20.
    • (1999) Toxicol Pathol , vol.27 , pp. 412-420
    • Kakinuma, C.1    Takagaki, K.2    Yatomi, T.3
  • 33
    • 0034032332 scopus 로고    scopus 로고
    • A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity
    • Ichikawa K, Yoshida-Kato H, Ohtsuki M, et al. A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. Int Immunol 2000;12:555-62.
    • (2000) Int Immunol , vol.12 , pp. 555-562
    • Ichikawa, K.1    Yoshida-Kato, H.2    Ohtsuki, M.3
  • 34
    • 0029003501 scopus 로고
    • Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
    • Owen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-40.
    • (1995) Mol Cell Biol , vol.15 , pp. 3032-3040
    • Owen-Schaub, L.B.1    Zhang, W.2    Cusack, J.C.3
  • 35
    • 0033748796 scopus 로고    scopus 로고
    • p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines
    • Petak I, Tillman DM, Houghton JA. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines. Clin Cancer Res 2000;6:4432-41.
    • (2000) Clin Cancer Res , vol.6 , pp. 4432-4441
    • Petak, I.1    Tillman, D.M.2    Houghton, J.A.3
  • 36
    • 0031806708 scopus 로고    scopus 로고
    • Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest
    • Ryan KM, Vousden KH. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 1998;18:3692-8.
    • (1998) Mol Cell Biol , vol.18 , pp. 3692-3698
    • Ryan, K.M.1    Vousden, K.H.2
  • 37
    • 0035862950 scopus 로고    scopus 로고
    • 727 phosphorylation, differentially affecting specific target gene expression
    • 727 phosphorylation, differentially affecting specific target gene expression. EMBO J 2001;20:91-100.
    • (2001) EMBO J , vol.20 , pp. 91-100
    • Kovarik, P.1    Mangold, M.2    Ramsauer, K.3
  • 38
    • 0033598839 scopus 로고    scopus 로고
    • 727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway
    • 727 requires p38 mitogen-activated protein kinase whereas IFN-γ uses a different signaling pathway. Proc Natl Acad Sci U S A 1999;96:13956-61.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 13956-13961
    • Kovarik, P.1    Stoiber, D.2    Eyers, P.A.3
  • 39
    • 0034383398 scopus 로고    scopus 로고
    • p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation
    • Takekawa M, Adachi M, Nakahata A, et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 2000;19:6517-26.
    • (2000) EMBO J , vol.19 , pp. 6517-6526
    • Takekawa, M.1    Adachi, M.2    Nakahata, A.3
  • 40
  • 41
    • 0032566691 scopus 로고    scopus 로고
    • Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
    • Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998;281:2042-5.
    • (1998) Science , vol.281 , pp. 2042-2045
    • Le Good, J.A.1    Ziegler, W.H.2    Parekh, D.B.3    Alessi, D.R.4    Cohen, P.5    Parker, P.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.